Last Updated 26 July 2021.
5 Vaccines Approved for Use in Iran (Islamic Republic of)
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 119 countries
33 trials in 19 countries
Approval Source: en.irna.ir
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 70 countries
19 trials in 7 countries
Approval Source: reuters.com
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
7 trials in 1 country
Approval Source: en.irna.ir
-
Shifa Pharmed Industrial Co
COVID-19 Inactivated Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
Approval Source: rferl.org
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 59 countries
7 trials in 7 countries
Approval Source: en.irna.ir
5 Vaccines in Clinical Trials in Iran (Islamic Republic of)
-
Shifa Pharmed Industrial Co
COVID-19 Inactivated Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
-
Vaxine
COVAX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Razi Vaccine and Serum Research Institute
Razi Cov Pars- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Organization of Defensive Innovation and Research
FAKHRAVAC (MIVAC)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Bagheiat-allah University of Medical Sciences
COVID-19 Recombinant RBD Protein Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country